67 results
Page 2 of 4
20-F/A
bf7u1bf61cbti
23 Mar 15
Annual report (foreign) (amended)
12:00am
424B5
4um0qy18gycaex lxerp
6 Mar 15
Prospectus supplement for primary offering
12:00am
424B5
32f77tv
5 Mar 15
Prospectus supplement for primary offering
12:00am
6-K
EX-99
mro5s0n6
10 Nov 14
BioLineRx Reports Third Quarter 2014 Financial Results
12:00am
6-K
EX-99
w2dxkms74r
10 Nov 14
BioLineRx Reports Third Quarter 2014 Financial Results
12:00am
6-K
EX-99
xlvsd
6 Aug 14
BioLineRx Reports Second Quarter 2014 Financial Results
12:00am
6-K
EX-99
6025e3zwo7cg5mf4z
6 Aug 14
BioLineRx Reports Second Quarter 2014 Financial Results
12:00am
424B2
421ribr0knze
13 Jun 14
Prospectus for primary offering
12:00am
F-3
vp04eof1nonh3e wwmn
30 May 14
Shelf registration (foreign)
12:00am
6-K
EX-99
fm8ypbkwroleb1ic0sh
20 May 14
BioLineRx Reports First Quarter 2014 Financial Results
12:00am
6-K
EX-99
qqtqsr
20 May 14
BioLineRx Reports First Quarter 2014 Financial Results
12:00am
6-K
EX-99
06qn cmrmej
17 Mar 14
BioLineRx Reports Year End 2013 Financial Results
12:00am
6-K
EX-1.1
k2dsf
7 Mar 14
BioLineRx Closes $24.1 Million Underwritten Public Offering
12:00am
424B5
vifzawvu alycng
4 Mar 14
Prospectus supplement for primary offering
12:00am
424B5
s9j84buo4 el1b9
3 Mar 14
Prospectus supplement for primary offering
12:00am
424B3
f7d08h czp467xbqw5
8 Aug 13
Prospectus supplement
12:00am
6-K
EX-99
oibpb 74s
6 Aug 13
BioLineRx Reports Second Quarter 2013 Results
12:00am
6-K
EX-99
tqn7b
6 Aug 13
BioLineRx Reports Second Quarter 2013 Results
12:00am
424B5
frv8feqqgphg8u3cx
17 May 13
Prospectus supplement for primary offering
12:00am